PBI4 Outcomes with Infliximab and Its Biosimilars in Patients with Rheumatoid Arthritis (RA): Real-World Experience in the US
Jun 1, 2021, 00:00 AM
10.1016/j.jval.2021.04.075
https://www.valueinhealthjournal.com/article/S1098-3015(21)00292-8/fulltext
Section Title :
Section Order :
10203
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00292-8&doi=10.1016/j.jval.2021.04.075